Madissoon, Elo
Oliver, Amanda J. http://orcid.org/0000-0003-1690-9027
Kleshchevnikov, Vitalii
Wilbrey-Clark, Anna
Polanski, Krzysztof http://orcid.org/0000-0002-2586-9576
Richoz, Nathan
Ribeiro Orsi, Ana http://orcid.org/0000-0002-4939-1423
Mamanova, Lira http://orcid.org/0000-0003-1463-8622
Bolt, Liam
Elmentaite, Rasa http://orcid.org/0000-0001-7366-5466
Pett, J. Patrick http://orcid.org/0000-0002-5249-444X
Huang, Ni
Xu, Chuan
He, Peng http://orcid.org/0000-0002-2457-3554
Dabrowska, Monika
Pritchard, Sophie
Tuck, Liz http://orcid.org/0000-0002-1837-7549
Prigmore, Elena http://orcid.org/0000-0001-8870-0316
Perera, Shani
Knights, Andrew
Oszlanczi, Agnes
Hunter, Adam
Vieira, Sara F. http://orcid.org/0000-0002-1021-3021
Patel, Minal
Lindeboom, Rik G. H. http://orcid.org/0000-0002-3660-504X
Campos, Lia S.
Matsuo, Kazuhiko
Nakayama, Takashi http://orcid.org/0000-0002-8493-899X
Yoshida, Masahiro http://orcid.org/0000-0002-3521-5322
Worlock, Kaylee B. http://orcid.org/0000-0002-5656-7634
Nikolić, Marko Z. http://orcid.org/0000-0001-6304-6848
Georgakopoulos, Nikitas http://orcid.org/0000-0002-1879-6583
Mahbubani, Krishnaa T. http://orcid.org/0000-0002-1327-2334
Saeb-Parsy, Kourosh http://orcid.org/0000-0002-0633-3696
Bayraktar, Omer Ali http://orcid.org/0000-0001-6055-277X
Clatworthy, Menna R.
Stegle, Oliver
Kumasaka, Natsuhiko http://orcid.org/0000-0002-3557-0375
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Article History
Received: 26 July 2022
Accepted: 25 October 2022
First Online: 21 December 2022
Competing interests
: In the past three years, SAT has received remuneration for consulting and Scientific Advisory Board Membership from Genentech, Roche, Biogen, GlaxoSmithKline, Foresite Labs and Qiagen. SAT is a cofounder, board member and holds equity in Transition Bio. OS is a paid member of the Scientific Advisory Board of Insitro. The remaining authors declare no competing interests.